Impact of RxPONDER and monarchE on the Surgical Management of the Axilla in Patients With Breast Cancer

Abstract GS4-03: Patient-reported outcomes (PROs) for the intergroup sentinel mamma study (INSEMA, GBG75, ABCSG43): Persistent impact of axillary surgery on arm and breast symptoms in early breast cancer

(2022) Bernd Gerber et al.   CANCER RESEARCH

Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast Cancer

(2021) Olga Kantor et al.   JNCI-Journal of the National Cancer Institute

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

(2021) Kevin Kalinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

(2020) Stephen R. D. Johnston et al.   JOURNAL OF CLINICAL ONCOLOGY

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

(2018) Prudence A. Francis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2017) Armando E. Giuliano et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

(2016) Armando E. Giuliano et al.   ANNALS OF SURGERY

Impact of Body Mass Index on Clinical Axillary Nodal Assessment in Breast Cancer Patients

(2016) Damian McCartan et al.   ANNALS OF SURGICAL ONCOLOGY

Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection?

(2016) Melissa Pilewskie et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Estrogen Receptor, Progesterone Receptor, and HER2 Status Predict Lymphovascular Invasion and Lymph Node Involvement

(2014) Stacy Ugras et al.   ANNALS OF SURGICAL ONCOLOGY

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

(2014) Mila Donker et al.   LANCET ONCOLOGY

Utility of Preoperative Ultrasound for Predicting pN2 or Higher Stage Axillary Lymph Node Involvement in Patients With Newly Diagnosed Breast Cancer

(2013) Hiroyuki Abe et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Feasibility of sentinel lymph node biopsy in breast cancer patients clinically suspected of axillary lymph node metastasis on preoperative imaging

(2013) Hee Kwak et al.   World Journal of Surgical Oncology

Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2011) Armando E. Giuliano   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION